You are here

IID-11.5 Data Details

Expand All

IID-11.5 Increase the vaccination coverage level of 3 doses of human papillomavirus (HPV) vaccine for males by age 13 to 15 years

About the Data: National

Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.

Data Source: 
National Immunization Survey-Teen (NIS-Teen); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Changed Since the Healthy People 2020 Launch: 
Yes
Measure: 
percent
Baseline (Year): 
6.9 (2012)
Target: 
80.0
Target-Setting Method: 
Maintain consistency with national programs, regulations, policies, and laws.
Numerator: 

Number of males aged 13 through 15 years who have received at least 3 doses of the human papillomavirus (HPV) vaccine

Denominator: 

Number of males aged 13 through 15 years

Comparable Healthy People 2010 Objective: 
Not applicable
Questions Used to Obtain the National Baseline Data: 

    From the 2013 National Immunization Survey-Teen Provider-Immunization History Questionnaire:

    [NUMERATOR:]

    Specify month, day, and year that each vaccine was given, either by the office or another provider, and type of vaccine, as documented in the records.

Data Collection Frequency: 
Annual
Methodology Notes: 

    The National Immunization Survey (NIS)-Teen collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, and other selected sub-state areas and U.S.-affiliated jurisdictions, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13–15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household and provider nonresponse, and exclusion of households without telephone service.

    On October 25, 2011, the Advisory Committing on Immunization Practices (ACIP) recommended a routine 3-dose series of human papillomavirus vaccination (HPV4) for males aged 11–12 years and catchup vaccination for males aged 13–21 years who have not been previously vaccinated or who have not completed the 3-dose series; males aged 22–26 years may be vaccinated.

    This measure tracks the proportion of male adolescents aged 13–15 years receiving at least 3 doses of the quadrivalent human papillomavirus vaccine.

About the Data: State

Description of the data source, numerator, denominator, survey questions, and other relevant details about the state-level data.

Data Source: 
National Immunization Survey-Teen (NIS-Teen); Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics (CDC/NCIRD and CDC/NCHS)
Measure: 
percent
Numerator: 

Number of males aged 13 through 15 years who have received at least 3 doses of the human papillomavirus (HPV) vaccine

Denominator: 

Number of males aged 13 through 15 years

Questions Used to Obtain the State Data: 

      From the 2013 National Immunization Survey-Teen Provider-Immunization History Questionnaire:

      [NUMERATOR:]

      Specify month, day, and year that each vaccine was given, either by the office or another provider, and type of vaccine, as documented in the records.

Data Collection Frequency: 
Annual
Methodology Notes: 

      The National Immunization Survey (NIS)-Teen collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, and other selected sub-state areas and U.S.-affiliated jurisdictions, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13–15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household and provider nonresponse, and exclusion of households without telephone service.

      On October 25, 2011, the Advisory Committing on Immunization Practices (ACIP) recommended a routine 3-dose series of human papillomavirus vaccination (HPV4) for males aged 11–12 years and catchup vaccination for males aged 13–21 years who have not been previously vaccinated or who have not completed the 3-dose series; males aged 22–26 years may be vaccinated.

      This measure tracks the proportion of male adolescents aged 13–15 years receiving at least 3 doses of the quadrivalent human papillomavirus vaccine.

Revision History

Any change to the objective text, baseline, target, target-setting method or data source since the Healthy People 2020 launch.

Description of Changes Since the Healthy People 2020 Launch: 
This objective was added to Healthy People 2020 in 2014.

References

Additional resources about the objective

  1. Datasets for the National Immunization Survey - Teen [online]. Atlanta (GA): National Center for Immunization and Respiratory Diseases. c2013 – [cited 2013 June 6].